Trial
NCT03168906
Renal AL Amyloid Involvement and NEOD001
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Tufts Medical Center
Collaborators
—
Condition
Amyloidosis
Intervention
NEOD001
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-09